JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Atrial Fibrillation: The Quivering Atria and the Stroke Risk

The most common serious arrhythmia. Understand why the atria stop beating and start quivering, why that raises stroke risk, and the two big decisions doctors make: rate or rhythm, and whether to thin the blood.

Why the atria quiver

In atrial fibrillation (AF), the orderly single wave from the SA node is replaced by a storm of chaotic electrical wavelets swirling through the atria — often hundreds of impulses a minute. The atria no longer contract in a clean squeeze; they quiver, or fibrillate. On the ECG, the tidy P waves vanish, replaced by a wavy baseline, and because the AV node passes impulses through at unpredictable moments, the QRS complexes come at irregular intervals. This is the classic “irregularly irregular” pulse you can sometimes feel at the wrist.

AF often feels like fluttering or racing palpitations, breathlessness, or fatigue — but many people feel nothing at all. A close cousin, atrial flutter, uses a single large re-entry loop in the right atrium and produces a more organized, sawtooth pattern; it carries similar risks and is treated along similar lines.

Why AF threatens the brain

Here is the real danger. When the atria quiver instead of squeezing, blood pools and stagnates, especially in a small pouch called the left atrial appendage. Stagnant blood clots. If a clot breaks loose, it can travel to the brain and cause a stroke. This is why AF, though rarely an emergency by itself, is one of the most important preventable causes of stroke — and why the central treatment decision is often about the blood, not the rhythm.

Doctors estimate each person's stroke risk with a simple score called CHA₂DS₂-VASc, which adds points for conditions like heart failure, high blood pressure, age, diabetes, prior stroke, vascular disease, and sex. The higher the score, the greater the yearly stroke risk, and the stronger the case for an anticoagulant — a blood thinner — to prevent clots.

CHA2DS2-VASc — estimating stroke risk in atrial fibrillation

  C   Congestive heart failure ............. 1 point
  H   Hypertension ......................... 1 point
  A2  Age >= 75 years ...................... 2 points
  D   Diabetes ............................. 1 point
  S2  prior Stroke / clot .................. 2 points
  V   Vascular disease ..................... 1 point
  A   Age 65-74 years ...................... 1 point
  Sc  Sex category (female) ................ 1 point

Worked example: a 78-year-old woman with high blood
pressure and diabetes
  Age >= 75 .......... 2
  Hypertension ....... 1
  Diabetes ........... 1
  Female ............. 1
  ------------------------
  TOTAL = 5  -> high yearly stroke risk
               -> blood thinner strongly favored

(A higher score means more benefit from anticoagulation.
 The actual decision is made with a clinician.)
How a stroke-risk score guides the decision to use a blood thinner. Illustrative — not a self-assessment.

Rate, rhythm, and the clot question

Managing AF means juggling two separate questions. The first is the heartbeat itself: should we simply slow the ventricles down (rate control, usually with a beta-blocker or similar drug), or try to restore normal rhythm (rhythm control, with antiarrhythmic medication, an electrical shock, or catheter ablation that burns the misfiring tissue)? The second question — usually the more important one — is the clot risk, decided largely independently of the first.